Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 49
2000 65
2001 88
2002 83
2003 101
2004 110
2005 188
2006 181
2007 174
2008 143
2009 119
2010 151
2011 218
2012 195
2013 264
2014 154
2015 176
2016 247
2017 273
2018 201
2019 199
2020 204
2021 195
2022 183
2023 147
2024 161
2025 142

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,723 results

Results by year

Filters applied: . Clear all
Page 1
Does RSClin provide additional information over classic clinico-pathologic scores (PREDICT 2.1, INFLUENCE 2.0, CTS5)?
Beltran-Bless AA, Pond GR, Bayani J, Barker SL, Spears M, Mallon E, Taylor KJ, Hasenburg A, Markopoulos C, Dirix L, Meershoek-Klein Kranenbarg E, van de Velde CJH, Rea DW, Vandermeer L, Hilton J, Bartlett JMS, Clemons M. Beltran-Bless AA, et al. Breast. 2025 Jul 4;83:104528. doi: 10.1016/j.breast.2025.104528. Online ahead of print. Breast. 2025. PMID: 40633461
Corrigendum to "Neoadjuvant chemotherapy for breast cancer in Italy: A Senonetwork analysis of 37,215 patients treated from 2017 to 2022" [The Breast 78 (2024) 103790].
De Luca A, Amabile MI, Santori F, Di Matteo S, Tomatis M, Ponti A, Frusone F, Taffurelli M, Tinterri C, Marotti L, Calabrese M, Marchiò C, Puglisi F, Palumbo I, Fortunato L; Senonet Collaborative Group. De Luca A, et al. Breast. 2025 Jun 26:104511. doi: 10.1016/j.breast.2025.104511. Online ahead of print. Breast. 2025. PMID: 40579240 Free article. No abstract available.
Partial breast irradiation after sentinel lymph node biopsy omission: Is it a valid alternative to whole breast Irradiation? Analysis of the dose to the sentinel lymph node region during whole breast irradiation vs. partial breast irradiation.
Behzadi ST, Moser R, Düsberg M, Aigner M, Nano J, Kiesl S, Lammert J, Klein E, Schmidt GP, Kiechle M, Huber T, Corradini S, Combs SE, Borm KJ. Behzadi ST, et al. Breast. 2025 Jun 25;82:104523. doi: 10.1016/j.breast.2025.104523. Online ahead of print. Breast. 2025. PMID: 40609502 Free article.
Hyaluronic acid 0.2 % cream for preventing radiation dermatitis in breast cancer patients treated with postoperative radiotherapy: A randomized, double-blind, placebo-controlled study.
Deantonio L, Borgonovo G, Caverzasio S, Piliero MA, Canino P, Puliatti A, Zilli T, Valli MC, Richetti A; Study 18CH-Iccr05 Investigators. Deantonio L, et al. Breast. 2025 Jun 12;82:104513. doi: 10.1016/j.breast.2025.104513. Online ahead of print. Breast. 2025. PMID: 40540938 Free PMC article.
Body mass index and progesterone receptor in postmenopausal ER-positive/HER2-negative breast cancer: A nation-wide study in Korean breast cancer society and the multi-institutional cohort.
Lee J, Bae SJ, Kim HK, Nam SJ, Kim HJ, Bae SY, Park HY, Ko BK, Park JH, Kwon Y, Park Y, Baek SH, Kook Y, Kim S, Lim YA, Kang HJ, Kim D, Jeong J, Ahn SG. Lee J, et al. Breast. 2025 Jun 9;82:104515. doi: 10.1016/j.breast.2025.104515. Online ahead of print. Breast. 2025. PMID: 40527014 Free PMC article.
CADONOT: Comparing axillary dissection or not in breast cancer surgery.
Mattar A, Antonini M, Cavalcante FP, Zerwes F, Millen EC, Brenelli FP, Frasson AL, Baruel PC, Okumura LM, Soares LR, Madeira M, Teixeira MD, Amorim AG, de Oliveira LC, Ramos MDNM, Facina G, de Freitas Junior R, Couto HL, Rondelo SM, Leite RM, Arakelian R, Gebrim LH, Real JM. Mattar A, et al. Breast. 2025 Jun;81:104453. doi: 10.1016/j.breast.2025.104453. Epub 2025 Mar 20. Breast. 2025. PMID: 40220731 Free PMC article. Review.
Paclitaxel-related type I Kounis Syndrome in a very young patient with HER2-positive breast cancer and the role of genomics to disentangle a complex therapeutic scenario: a case report and narrative review.
Muñoz J, Nucera S, Rubira Garcia N, Cebrecos I, Oses G, Ganau S, Sanfeliu E, Jares P, Marín-Aguilera M, Galván P, Brasó-Maristany F, Martínez-Sáez O, Cascos E, Font C, Schettini F. Muñoz J, et al. Breast. 2025 Jun;81:104465. doi: 10.1016/j.breast.2025.104465. Epub 2025 Apr 4. Breast. 2025. PMID: 40199689 Free PMC article. Review.
Clinical characteristics and prognostic factors in patients with breast cancer and leptomeningeal metastases from a large registry of BMBC.
Laakmann E, Schmidt M, Lübbe K, Agostinetto E, van Ramshorst M, Decker T, Malter W, Schettini F, Sousa MF, Denkert C, Neunhöffer T, Matos L, Linn S, Thill M, Weide R, Fitzpatrick A, Batista MV, Mundhenke C, Park-Simon TW, Le Du F, Riecke K, Fehm T, Witzel I, Rey J, Nekljudova V, Loibl S, Müller V. Laakmann E, et al. Breast. 2025 Jun;81:104433. doi: 10.1016/j.breast.2025.104433. Epub 2025 Mar 28. Breast. 2025. PMID: 40187267 Free PMC article.
Patient perception on risk of recurrence and decision-making in the management of HER2-positive early breast cancer: Insights from the ASKHER2 European survey.
Lambertini M, Jackisch C, Trédan O, Vidal M, Fontes-Sousa M, Valachis A, D'Antona R, Ruz M, Krone E, Brice M, Berjonneau E, Matos S, Dialla O, Guéroult-Accolas L. Lambertini M, et al. Breast. 2025 Jun;81:104456. doi: 10.1016/j.breast.2025.104456. Epub 2025 Mar 21. Breast. 2025. PMID: 40158495 Free PMC article.
Real-world utilization of aromatase inhibitors, tamoxifen, and ovarian function suppression in premenopausal patients with early hormone receptor-positive, HER2-negative breast cancer with increased recurrence risk.
Müller V, Hörner M, Thill M, Banys-Paluchowski M, Schmatloch S, Fasching PA, Harbeck N, Langanke D, Uhrig S, Häberle L, Fischer D, Hein A, Fehm TN, Goossens C, Terhaag J, Heilenkötter U, Dall P, Rudlowski C, Wuerstlein R, Aydogdu M, Keyver-Paik MD, Hammerle C, Deuerling N, Stickeler E, Aktas B, Belleville E, Thoma M, Ditsch N, Baila Y, Roos C, Mann C, Iuliano C, Brucker SY, Schneeweiss A, Hartkopf AD. Müller V, et al. Breast. 2025 Jun;81:104458. doi: 10.1016/j.breast.2025.104458. Epub 2025 Mar 22. Breast. 2025. PMID: 40147402 Free PMC article.
Identifying germline pathogenic variants in breast cancer using tumor sequencing.
Cruellas M, Papakonstantinou A, López-Fernández A, Castillo E, Matito J, Gómez M, Rezqallah A, Vega S, Navarro V, Torres M, Moles-Fernández A, Saura C, Vivancos A, Balmaña J, Oliveira M. Cruellas M, et al. Breast. 2025 Jun;81:104439. doi: 10.1016/j.breast.2025.104439. Epub 2025 Mar 12. Breast. 2025. PMID: 40090122 Free PMC article.
Awareness of genomic testing among patients with breast cancer in Europe.
Cardone A, Bell D, Biurrun C, Cognetti F, Cardoso F, Piris AR, Degi C, Lux MP, Simcock R, Wassermann J, D'Antona R, Rubio IT. Cardone A, et al. Breast. 2025 Jun;81:104436. doi: 10.1016/j.breast.2025.104436. Epub 2025 Mar 5. Breast. 2025. PMID: 40058335 Free PMC article.
A composite 18F-FDG PET/CT and HER2 tissue-based biomarker to predict response to neoadjuvant pertuzumab and trastuzumab in HER2-positive breast cancer (TBCRC026).
Hennessy MA, Cimino-Mathews A, Carter JM, Kachergus JM, Ma Y, Leal JP, Solnes LB, Abramson VG, Carey LA, Rimawi M, Specht J, Storniolo AM, Vaklavas C, Krop I, Winer E, Denbow R, Valero V, Wolff AC, Wahl RL, Huang CY, Stearns V, Thompson EA, Connolly RM. Hennessy MA, et al. Breast. 2025 Jun;81:104432. doi: 10.1016/j.breast.2025.104432. Epub 2025 Mar 1. Breast. 2025. PMID: 40049115 Free PMC article.
Integrating genetic polymorphisms and clinical data to develop predictive models for skin toxicity in breast cancer radiation therapy.
Aguado-Flor E, Reyes VM, Navarro V, Mollà M, Aguado-Barrera ME, Altabas M, Azria D, Baten A, Bourgier C, Bultijnck R, Chang-Claude J, De Santis MC, Dunning AM, Duran-Lozano L, Elliott RM, Farcy Jacquet MP, Giandini C, Giraldo A, Green S, Lambrecht M, Lopez-Pleguezuelos C, Monten C, Rancati T, Rattay T, Rosenstein BS, De Ruysscher D, Diez O, Seibold P, Sperk E, Symonds RP, Stobart H, Vega A, Veldeman L, Villacampa G, Webb AJ, Weltens C, Zunino P, Talbot CJ, West CM, Giralt J, Gutiérrez-Enríquez S; REQUITE consortium. Aguado-Flor E, et al. Breast. 2025 May 22;82:104506. doi: 10.1016/j.breast.2025.104506. Online ahead of print. Breast. 2025. PMID: 40570703 Free article.
Comparative analysis of Denosumab and Zoledronic acid in advanced breast cancer patients receiving CDK4/6 inhibitors.
Scafetta R, Donato M, Gullotta C, Guarino A, Fiore C, Sisca L, Speziale E, Troiano R, Foderaro S, Ricozzi V, Iuliani M, Simonetti S, Cavaliere S, Cortellini A, Botticelli A, Scagnoli S, Pisegna S, Criscitiello C, Pedersini R, Sposetti C, Tiberi E, D'Auria G, Vergati M, Mazzotta M, Caputo R, Verrazzo A, Rossino MG, Domati F, Piombino C, Di Lisa FS, Filomeno L, Arcuri T, Puce F, Riva F, Palleschi M, Sirico M, Piras M, Stucci LS, De Lisi D, Orsaria P, Ippolito E, Ramella S, Visani L, Bertini N, Bonaparte I, Gori S, Rossi L, Meattini I, Tagliaferri B, Caffo O, Portarena I, Irelli A, Cretella E, Porta C, Bianchini G, Fabbri A, De Giorgi U, Vici P, Toss A, Garrone O, De Laurentiis M, Villa F, Berardi R, Minelli M, Vernieri C, Curigliano G, Vincenzi B, Tonini G, Santini D, Pantano F. Scafetta R, et al. Breast. 2025 May 15;82:104502. doi: 10.1016/j.breast.2025.104502. Online ahead of print. Breast. 2025. PMID: 40424680 Free PMC article.
Clinical genome sequencing in patients with hereditary breast and ovarian cancer: Concept, implementation and benefits.
Witt D, Sturm M, Stäbler A, Menden B, Ruisinger L, Bosse K, Gruber I, Hartkopf A, Gauß S, Demidov G, Casadei N, Atienza EB, Mehnert K, Witt J, Gross C, Schütz L, Schroeder C, Ossowski S, Dufke A, Haack TB, Riess O, Faust U. Witt D, et al. Breast. 2025 May 15;82:104505. doi: 10.1016/j.breast.2025.104505. Online ahead of print. Breast. 2025. PMID: 40403485 Free PMC article.
Nationwide real-world practice pattern and clinical data of palbociclib in HR (+), HER2 (-) metastatic breast cancer patients in Korea (KCSG BR21-15).
Lee J, Lee DW, Kim MH, Kim JH, Kim JW, Byun JH, Lee KE, Kang MJ, Koh SJ, Hong S, Won HS, Kim HJ, Park IH, Shin SH, Baek SK, Kim SG, Koh SA, Jung JY, Kim JY, Kim GM, Shin K, Woo IS, Kim HS, Im SA, Park YH. Lee J, et al. Breast. 2025 May 12;82:104500. doi: 10.1016/j.breast.2025.104500. Online ahead of print. Breast. 2025. PMID: 40383091 Free PMC article.
Advancing breast cancer therapy in the era of molecular diagnostics.
Carnevale MG, Colciago RR, De Santis MC, Cortesi L, De Marco C, Marra A, Vingiani A, Nolè F, Curigliano G, Pruneri G, Llombart-Cussac A, Di Cosimo S, Cortes J. Carnevale MG, et al. Breast. 2025 May 8;82:104488. doi: 10.1016/j.breast.2025.104488. Online ahead of print. Breast. 2025. PMID: 40424679 Free PMC article. Review.
Physicians' knowledge, practice, and attitudes on fertility and pregnancy-related issues in young women with advanced breast cancer: results of the ABC6 and ABC7 survey.
Nardin S, Arecco L, Delucchi V, Blondeaux E, Stana M, de Moura Leite L, Weis LN, Hoang GP, Daneri A, Bruzzone F, Meacci A, Molinelli C, Razeti MG, Perrone M, Paluch-Shimon S, Partridge AH, Cardoso F, Spanic T, Kufel-Grabowska J, Lambertini M. Nardin S, et al. Breast. 2025 Apr 24;82:104479. doi: 10.1016/j.breast.2025.104479. Online ahead of print. Breast. 2025. PMID: 40334324 Free PMC article.
Immune-related adverse events among patients with early-stage triple-negative breast cancer treated with pembrolizumab plus chemotherapy: real-world data from the Neo-Real/GBECAM 0123 study.
Andrade MO, Gutierres IG, Tavares MC, de Sousa IM, Balint FC, Marin Comini AC, Gouveia MC, Bines J, Madasi F, Ferreira RDP, Rosa DD, Santos CL, Assad-Suzuki D, de Souza ZS, de Araújo JAP, de Melo Gagliato D, Dos Anjos CH, Zucchetti BM, Ferrari A, de Brito ML, Cangussu R, Fernandes Monteiro MM, Hoff PM, Del Pilar Estevez-Diz M, Testa L, Barroso-Sousa R, Bonadio RC. Andrade MO, et al. Breast. 2025 Apr 10:104473. doi: 10.1016/j.breast.2025.104473. Online ahead of print. Breast. 2025. PMID: 40240201 Free article.
Validation of the CTS5 in four prospective, multicenter, randomized ABCSG trials.
Wimmer K, Hlauschek D, Balic M, Pfeiler G, Greil R, Singer CF, Halper S, Steger G, Suppan C, Gampenrieder SP, Helfgott R, Egle D, Filipits M, Jakesz R, Sölkner L, Fesl C, Gnant M, Fitzal F; Austrian Breast & Colorectal Cancer Study Group. Wimmer K, et al. Breast. 2025 Apr;80:104415. doi: 10.1016/j.breast.2025.104415. Epub 2025 Feb 19. Breast. 2025. PMID: 39985843 Free PMC article.
Disparities in access to anti-HER2 therapies in neoadjuvant chemotherapy: A prognostic analysis based on real-world data comparing Brazil's public and private healthcare systems.
Antonini M, Mattar A, Pereira da Costa Pinheiro DJ, Maia IB, Teixeira MD, Amorim AG, Ferraro O, Chrispim de Oliveira L, Ramos MDNM, Cavalcante FP, Zerwes F, Madeira M, Barroso-Sousa R, de Camargo Millen E, Frasson AL, Brenelli FP, Facina G, Fenile R, Gebrim LH, Real JM. Antonini M, et al. Breast. 2025 Apr;80:104417. doi: 10.1016/j.breast.2025.104417. Epub 2025 Feb 12. Breast. 2025. PMID: 39983435 Free PMC article.
Side-effects in women treated with adjuvant endocrine therapy for breast cancer.
Rademaker LM, Gal R, May AM, Batenburg MCT, van der Leij F, Bijlsma RM, Verkooijen HM, Doeksen A, Ernst MF, Evers DJ, van der Pol CC, Monninkhof EM. Rademaker LM, et al. Breast. 2025 Apr;80:104416. doi: 10.1016/j.breast.2025.104416. Epub 2025 Feb 11. Breast. 2025. PMID: 39978152 Free PMC article.
Omitting axillary lymph node dissection in breast cancer patients with extensive nodal disease and excellent response to primary systemic therapy using the MARI protocol.
van Hemert AKE, van Loevezijn AA, Baas MPD, Stokkel MPM, Groen EJ, van der Noort V, Loo CE, Sonke GS, Russell N, van Duijnhoven FH, Vrancken Peeters MTFD. van Hemert AKE, et al. Breast. 2025 Apr;80:104411. doi: 10.1016/j.breast.2025.104411. Epub 2025 Feb 4. Breast. 2025. PMID: 39954569 Free PMC article.
Updated efficacy and safety of HLX02 versus reference trastuzumab in metastatic HER2-positive breast cancer: A randomized phase III equivalence trial.
Xu B, Zhang Q, Sun T, Li W, Teng Y, Hu X, Bondarenko I, Adamchuk H, Zhang L, Trukhin D, Wang S, Zheng H, Tong Z, Shparyk Y, Yang F, Yu H, Li J, Wang Q, Zhu J; HLX02-BC01 Investigators. Xu B, et al. Breast. 2025 Apr;80:104413. doi: 10.1016/j.breast.2025.104413. Epub 2025 Feb 4. Breast. 2025. PMID: 39954568 Free PMC article. Clinical Trial.
Characteristics and prognosis of patients with primary metastatic disease vs. recurrent HER2-negative, hormone receptor-positive advanced breast cancer.
Walter CB, Hartkopf AD, Hein A, Fasching PA, Kolberg HC, Hadji P, Tesch H, Häberle L, Ettl J, Lüftner D, Wallwiener M, Müller V, Beckmann MW, Michel LL, Belleville E, Huebner H, Uhrig S, Goossens C, Wimberger P, Hielscher C, Meyer J, Mundhenke C, Kurbacher C, Wuerstlein R, Untch M, Janni W, Taran FA, Lux MP, Wallwiener D, Brucker SY, Schneeweiss A, Fehm TN, Fremd C. Walter CB, et al. Breast. 2025 Apr;80:104412. doi: 10.1016/j.breast.2025.104412. Epub 2025 Feb 5. Breast. 2025. PMID: 39952220 Free PMC article.
Corrigendum to 'Impact of adjuvant trastuzumab therapy and its discontinuation on cardiac function and mortality in patients with early-stage breast cancer: An analysis based on the Japanese Receipt Claim Database' [The Breast 79 (2025) 103871].
Miyazato K, Ohtsu H, Shimomura A, Yonemoto N, Shimizu C, Sase K, Ueda S. Miyazato K, et al. Breast. 2025 Apr;80:103894. doi: 10.1016/j.breast.2025.103894. Epub 2025 Feb 12. Breast. 2025. PMID: 39947088 Free PMC article. No abstract available.
An international Phase IV field study - psychometric properties of the updated module on assessing quality of life of patients with breast cancer EORTC QLQ-BR42.
Bjelic-Radisic V, Cardoso F, Weis J, Pogoda K, Arraras JI, Greimel E, Bottomley A, Cameron D, Brain E, Hartup S, da Costa Vieira RA, Hoefnagels N, Huang CC, Shamieh O, Pinto M, Belay YB, Serpentini S, Bleiker E, Nookala Krishnamurthy M, Shimomura A, Sturm-Inwald EC, Getu MA, Bliem B, Astrup G, Morag O, Kikawa Y, Kuljanic K, Nevries N, Sprangers M, Aaronson NK, Sinai P, Tomaszewski K, Galalae R, Conroy T, Duhoux F, Chie WC, Velikova G; EORTC Quality of Life Group and Breast Cancer Group. Bjelic-Radisic V, et al. Breast. 2025 Apr;80:103890. doi: 10.1016/j.breast.2025.103890. Epub 2025 Jan 27. Breast. 2025. PMID: 39947087 Free PMC article.
Multimodal data integration in early-stage breast cancer.
Llinas-Bertran A, Butjosa-Espín M, Barberi V, Seoane JA. Llinas-Bertran A, et al. Breast. 2025 Apr;80:103892. doi: 10.1016/j.breast.2025.103892. Epub 2025 Jan 28. Breast. 2025. PMID: 39922065 Free PMC article. Review.
Reply to the letter: What can paintings teach us?
Di Cosimo S, Perciaccante A, Donell ST, Wimmer J, Nerlich AG, DeWaal JC, Cortesi L, Bianucci R. Di Cosimo S, et al. Breast. 2025 Apr;80:103893. doi: 10.1016/j.breast.2025.103893. Epub 2025 Jan 28. Breast. 2025. PMID: 39893057 Free PMC article. No abstract available.
What can paintings teach us?
Śniadecki M, Malitowska A, Musielak O, Boyke Z, Aristei C. Śniadecki M, et al. Breast. 2025 Apr;80:103882. doi: 10.1016/j.breast.2025.103882. Epub 2025 Jan 20. Breast. 2025. PMID: 39856006 Free PMC article. No abstract available.
Joint analysis of germline genetic data from over 29,000 cases with suspected hereditary breast and ovarian cancer (HBOC) as part of the NASGE initiative.
Henkel J, Laner A, Locher M, Wohlfrom T, Neitzel B, Becker K, Neuhann T, Abicht A, Steinke-Lange V, Klink B, Eichhorn B, Schmidt W, Berner D, Teubert A, Holtorf A, Heinrich S, Wildhardt G, Schulze M, von der Heyden L, Hörtnagel K, Steinberger D, Kleier S, Lorenz P, Glaubitz R, Biskup S, Holinski-Feder E. Henkel J, et al. Breast. 2025 Apr;80:103887. doi: 10.1016/j.breast.2025.103887. Epub 2025 Jan 20. Breast. 2025. PMID: 39854808 Free PMC article.
The 2024 Assisi think tank on breast cancer: Focus on the use of a tumour bed boost after breast conserving therapy.
Arenas M, Bölükbaşı Y, Boersma LJ, Offersen B, Kouloulias V, Palumbo I, Trigo L, Lozza L, Marazzi F, Trovo M, Rivera S, Kaidar-Person O, Coles C, Meattini I, Valentini V, Aristei C, Poortmans P; Assisi Think Tank Meeting (ATTM) 2024 members. Arenas M, et al. Breast. 2025 Apr;80:103881. doi: 10.1016/j.breast.2025.103881. Epub 2025 Jan 20. Breast. 2025. PMID: 39854807 Free PMC article. Review.
Corrigendum to 'Raising awareness of alcohol as a modifiable risk factor for breast cancer: A randomized controlled trial comparing the efficacy of accessing an interactive website with a non-interactive website' [The Breast (2025) 103868].
Sardu C, Angius F, Contu P, Cosentino S, Deiana M, Fraschini M, Madeddu C, Massa E, Mereu A, Minerba L, Politi C, Puxeddu S, Salis F, Sinclair JMA, Agabio R. Sardu C, et al. Breast. 2025 Feb;79:103888. doi: 10.1016/j.breast.2025.103888. Epub 2025 Jan 24. Breast. 2025. PMID: 39856005 Free PMC article. No abstract available.
Implementation of model-informed precision dosing for tamoxifen therapy in patients with breast cancer: A prospective intervention study.
van Nijnatten RYM, Buijs SM, Agema BC, Fischer RMJ, Moghaddam-Helmantel IG, Contant CME, de Jongh FE, Huijben AMT, Kop M, van der Padt-Pruijsten A, Zuetenhorst HJM, van Schaik RHN, Koch BCP, Jager A, Koolen SLW, Mathijssen RHJ. van Nijnatten RYM, et al. Breast. 2025 Feb;79:103880. doi: 10.1016/j.breast.2025.103880. Epub 2025 Jan 9. Breast. 2025. PMID: 39813819 Free PMC article.
The impact on productivity costs of reducing unemployment in patients with advanced breast cancer: A model estimation based on a Portuguese nationwide observational study.
Vasconcelos de Matos L, Borges M, Oliveira AT, Bulhosa C, Miguel LS, Fidalgo de Freitas T, Cunha R, Mendes AD, Arede AJ, Marques C, Costa DA, Correia JA, Brito M, Fontes E Sousa M, Guimarães T, Cardoso F. Vasconcelos de Matos L, et al. Breast. 2025 Feb;79:103867. doi: 10.1016/j.breast.2024.103867. Epub 2024 Dec 26. Breast. 2025. PMID: 39753059 Free PMC article.
Raising awareness of alcohol as a modifiable risk factor for breast cancer: A randomized controlled trial comparing the efficacy of accessing an interactive website with a non-interactive website.
Sardu C, Angius F, Contu P, Cosentino S, Deiana M, Fraschini M, Madeddu C, Massa E, Mereu A, Minerba L, Politi C, Puxeddu S, Salis F, Sinclair JMA, Agabio R. Sardu C, et al. Breast. 2025 Feb;79:103868. doi: 10.1016/j.breast.2024.103868. Epub 2024 Dec 26. Breast. 2025. PMID: 39736191 Free PMC article. Clinical Trial.
Adipocyte heterogeneity and tumor infiltration of adipose tissue in patients with metastatic breast cancer.
Izci H, Zels G, Pabba A, Maetens M, Richard F, De Schepper M, Van Cauwenberge J, Nguyen HL, Borremans K, Leduc S, Van Baelen K, Hatse S, Geukens T, Mahdami A, Wildiers H, Neven P, Van Den Bogaert W, Floris G, Desmedt C. Izci H, et al. Breast. 2025 Feb;79:103852. doi: 10.1016/j.breast.2024.103852. Epub 2024 Nov 26. Breast. 2025. PMID: 39626345 Free PMC article.
A patient-led survey on information and communication needs of patients with metastatic breast cancer in Ireland and Northern Ireland (CTRIAL-IE 23-05).
Gaynor S, O'Meara Y, Mulvaney E, Keogh RJ, Weadick CS, Duane FJ, Mc Brien A, Greally H, O'Leary MJ, Teiserskyte I, Beristain I, Marron J, Mulroe E, Donachie V, Mc Loughlin S, O'Reilly S. Gaynor S, et al. Breast. 2025 Feb;79:103837. doi: 10.1016/j.breast.2024.103837. Epub 2024 Nov 20. Breast. 2025. PMID: 39591880 Free PMC article.
The INFLUENCE 3.0 model: Updated predictions of locoregional recurrence and contralateral breast cancer, now also suitable for patients treated with neoadjuvant systemic therapy.
Van Maaren MC, Hueting TA, van Uden DJP, van Hezewijk M, de Munck L, Mureau MAM, Seegers PA, Voorham QJM, Schmidt MK, Sonke GS, Groothuis-Oudshoorn CGM, Siesling S; NABOR project group. Van Maaren MC, et al. Breast. 2025 Feb;79:103829. doi: 10.1016/j.breast.2024.103829. Epub 2024 Oct 28. Breast. 2025. PMID: 39541608 Free PMC article.
Olaparib monotherapy in advanced triple-negative breast cancer patients with homologous recombination deficiency and without germline mutations in BRCA1/2: The NOBROLA phase 2 study.
Cortés A, López-Miranda E, Fernández-Ortega A, Carañana V, Servitja S, Urruticoechea A, Lema-Roso L, Márquez A, Lazaris A, Alcalá-López D, Mina L, Gener P, Rodríguez-Morató J, Antonarelli G, Llombart-Cussac A, Pérez-García J, Cortés J. Cortés A, et al. Breast. 2024 Dec;78:103834. doi: 10.1016/j.breast.2024.103834. Epub 2024 Nov 3. Breast. 2024. PMID: 39520738 Free PMC article. Clinical Trial.
Neoadjuvant chemotherapy for radiation associated angiosarcoma (RAAS) of the breast: A retrospective single center study.
van der Burg SJC, Reijers SJM, Kuijpers A, Heimans L, Scholten AN, Haas RLM, Boven HV, Kolff WM, Vrancken Peeters MTFD, Kerst M, Seinstra BA, Steeghs N, van der Graaf WTA, Schrage YM, van Houdt WJ. van der Burg SJC, et al. Breast. 2024 Dec;78:103825. doi: 10.1016/j.breast.2024.103825. Epub 2024 Oct 21. Breast. 2024. PMID: 39476458 Free PMC article.
The efficacy and safety of CDK4/6 inhibitors combined with endocrine therapy versus endocrine therapy alone in the adjuvant treatment of patients with high-risk invasive HR+/HER2-early breast cancer: A comprehensive updated meta-analysis of randomized clinical trials.
Keskinkilic M, Arayici ME, Basbinar Y, Ellidokuz H, Yavuzsen T, Oztop I. Keskinkilic M, et al. Breast. 2024 Dec;78:103815. doi: 10.1016/j.breast.2024.103815. Epub 2024 Oct 15. Breast. 2024. PMID: 39413680 Free PMC article.
Clinical significance of serum estradiol monitoring in women receiving adjuvant aromatase inhibitor for hormone receptor-positive early breast cancer.
Dai S, Wu X, Huang X, Li J, Wang X, Wang S, Tang J, Shi Y, Xie X, Xu F, Liu P, Huang J, Xie X, An X, Chen M, Hong R, Xia W, Zheng Q, Jiang K, Zhong Y, Yuan Z, Huang Y, Bi X, Xue C. Dai S, et al. Breast. 2024 Dec;78:103818. doi: 10.1016/j.breast.2024.103818. Epub 2024 Sep 29. Breast. 2024. PMID: 39357125 Free PMC article.
Role of [18F]FDG PET/CT in patients with invasive breast carcinoma of no special type: Literature review and comparison between guidelines.
Groheux D, Vaz SC, Poortmans P, Mann RM, Ulaner GA, Cook GJR, Hindié E, Pilkington Woll JP, Jacene H, Rubio IT, Vrancken Peeters MJ, Dibble EH, de Geus-Oei LF, Graff SL, Cardoso F. Groheux D, et al. Breast. 2024 Dec;78:103806. doi: 10.1016/j.breast.2024.103806. Epub 2024 Sep 12. Breast. 2024. PMID: 39303572 Free PMC article. Review.
Body composition in early breast cancer patients treated with adjuvant aromatase inhibitors: Does dietary counseling matter?
Pedersini R, Schivardi G, Laganà M, Laini L, di Mauro P, Zamparini M, Amoroso V, Bonalumi A, Bosio S, Zanini B, Buizza C, Villa N, Ravanelli M, Rinaudo L, Grisanti S, Farina D, Berruti A, Donato F, Cosentini D. Pedersini R, et al. Breast. 2024 Dec;78:103794. doi: 10.1016/j.breast.2024.103794. Epub 2024 Aug 31. Breast. 2024. PMID: 39265313 Free PMC article.
Real-world prevalence, treatment and survival of "high risk" early breast cancer, with mandatory testing of gBRCA1/2 mutation according to the OlympiA trial inclusion criteria: Data from a population-based registry.
Ladoire S, Mamguem Kamga A, Galland L, Desmoulins I, Mayeur D, Kaderbhai C, Ilie SM, Hennequin A, Jankowski C, Albuisson J, Nambot S, Coutant C, Arnould L, Reda M, Truntzer C, Dabakuyo S. Ladoire S, et al. Breast. 2024 Dec;78:103789. doi: 10.1016/j.breast.2024.103789. Epub 2024 Aug 28. Breast. 2024. PMID: 39243563 Free PMC article.
Neoadjuvant chemotherapy for breast cancer in Italy: A Senonetwork analysis of 37,215 patients treated from 2017 to 2022.
De Luca A, Amabile MI, Santori F, Di Matteo S, Tomatis M, Ponti A, Frusone F, Taffurelli M, Tinterri C, Marotti L, Calabrese M, Marchiò C, Puglisi F, Palumbo I, Fortunato L; Senonet Collaborative Group*. De Luca A, et al. Breast. 2024 Dec;78:103790. doi: 10.1016/j.breast.2024.103790. Epub 2024 Aug 30. Breast. 2024. PMID: 39242318 Free PMC article.
Use of tamoxifene-controlled ovarian hyperstimulation for fertility preservation before breast cancer treatment: A prospective cohort study with a 5-year follow-up.
Dezellus A, Mirallie S, Leperlier F, Sauterey B, Bouet PE, Dessaint A, Duros S, Gremeau AS, Mouret-Reynier MA, Durand LM, Venat L, De Blay P, Robert M, Freour T, Campone M, Blanc-Lapierre A, Bordes V. Dezellus A, et al. Breast. 2024 Oct;77:103776. doi: 10.1016/j.breast.2024.103776. Epub 2024 Aug 3. Breast. 2024. PMID: 39167853 Free PMC article.
Olaparib plus trastuzumab in HER2-positive advanced breast cancer patients with germline BRCA1/2 mutations: The OPHELIA phase 2 study.
Alés-Martínez JE, Balmaña J, Sánchez-Rovira P, Salvador Bofill FJ, García Sáenz JÁ, Pimentel I, Morales S, Fernández-Abad M, Lahuerta Martínez A, Ferrer N, Zamora P, Bermejo B, Díaz-Redondo T, López-Ceballos MH, Galán M, Pérez-Escuredo J, Calabuig L, Sampayo M, Pérez-Garcia JM, Cortés J, Llombart-Cussac A. Alés-Martínez JE, et al. Breast. 2024 Oct;77:103780. doi: 10.1016/j.breast.2024.103780. Epub 2024 Aug 2. Breast. 2024. PMID: 39116683 Free PMC article. Clinical Trial.
Psychometric properties of patient-reported outcomes Common Terminology Criteria for adverse events (PRO-CTCAE®) in breast cancer patients: The prospective observational multicenter VIP study.
Caminiti C, Maglietta G, Arenare L, Di Liello R, Migliaccio G, Barberio D, De Laurentiis M, Di Rella F, Nuzzo F, Pacilio C, Iodice G, Orditura M, Ciardiello F, Di Bella S, Cavanna L, Porta C, Giovanardi F, Ripamonti CI, Bilancia D, Aprile G, Ruelle T, Diodati F, Piccirillo MC, Iannelli E, Pinto C, Perrone F. Caminiti C, et al. Breast. 2024 Oct;77:103781. doi: 10.1016/j.breast.2024.103781. Epub 2024 Jul 20. Breast. 2024. PMID: 39059033 Free PMC article.
Adjuvant endocrine therapy choices in premenopausal patients with hormone receptor-positive early breast cancer: Insights from the prospective GIM23-POSTER study.
Arecco L, Latocca MM, Blondeaux E, Riccardi F, Mocerino C, Guarneri V, Mioranza E, Bisagni G, Gasparini E, Puglisi F, Membrino A, Ferro A, Adamo V, Giovanardi F, Tamberi S, Donati S, Landucci E, Biganzoli L, Piccinini S, Pastorino S, de Azambuja E, Poggio F, Lambertini M, Del Mastro L. Arecco L, et al. Breast. 2024 Oct;77:103769. doi: 10.1016/j.breast.2024.103769. Epub 2024 Jul 9. Breast. 2024. PMID: 39043079 Free PMC article.
Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancer.
Pagan E, Ruggeri M, Bianco N, Bucci EO, Graffeo R, Borner M, Giordano M, Gianni L, Rabaglio M, Freschi A, Cretella E, Seles E, Farolfi A, Simoncini E, Ciccarese M, Rauch D, Favaretto A, Honecker F, Berardi R, Franzetti-Pellanda A, Gelber S, Partridge AH, Goldhirsch A, Bagnardi V, Pagani O, Ribi K. Pagan E, et al. Breast. 2024 Oct;77:103765. doi: 10.1016/j.breast.2024.103765. Epub 2024 Jul 4. Breast. 2024. PMID: 39002281 Free PMC article.
DCIS knowledge of women choosing between active surveillance and surgery for low-risk DCIS.
Engelhardt EG, Schmitz RSJM, Gerritsma MA, Sondermeijer CMT, Verschuur E, Houtzager JHE, Griffioen R, Bijker N, Mann RM, Retèl V, van Duijnhoven FH, Wesseling J, Bleiker EMA; Grand Challenge PRECISION Consortium. Engelhardt EG, et al. Breast. 2024 Oct;77:103764. doi: 10.1016/j.breast.2024.103764. Epub 2024 Jul 2. Breast. 2024. PMID: 38970983 Free PMC article.
Cropsi study: Efficacy and safety of cryotherapy and cryocompression in the prevention of chemotherapy-induced peripheral neuropathy in patients with breast and gynecological cancer-A prospective, randomized trial.
Brunner C, Emmelheinz M, Egle D, Ritter M, Leitner K, Wieser V, Albertini C, Abdel Azim S, Mutz-Dehbalaie I, Kögl J, Marth C. Brunner C, et al. Breast. 2024 Aug;76:103763. doi: 10.1016/j.breast.2024.103763. Epub 2024 Jun 26. Breast. 2024. PMID: 38941655 Free PMC article. Clinical Trial.
The features of male breast cancer in China: A real-world study.
Gao Y, Zhang M, Sun G, Ma L, Nie J, Yuan Z, Liu Z, Cao Y, Li J, Liu Q, Ye S, Chen B, Song Y, Wang K, Ren Y, Ye G, Xu L, Liu S, Chen Q, Li W, Chen X, Fu P, Wei W, Guo B, Wang H, Cai Z, Du C, Wu Z, Zha X, Huang H, Xu J, Zhang C, Shi Y, Liu T, Liu S, Jiang Z, Lin Y. Gao Y, et al. Breast. 2024 Aug;76:103762. doi: 10.1016/j.breast.2024.103762. Epub 2024 Jun 22. Breast. 2024. PMID: 38924994 Free PMC article.
6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7).
Cardoso F, Paluch-Shimon S, Schumacher-Wulf E, Matos L, Gelmon K, Aapro MS, Bajpai J, Barrios CH, Bergh J, Bergsten-Nordström E, Biganzoli L, Cardoso MJ, Carey LA, Chavez-MacGregor M, Chidebe R, Cortés J, Curigliano G, Dent RA, El Saghir NS, Eniu A, Fallowfield L, Francis PA, Franco Millan SX, Gilchrist J, Gligorov J, Gradishar WJ, Haidinger R, Harbeck N, Hu X, Kaur R, Kiely B, Kim SB, Koppikar S, Kuper-Hommel MJJ, Lecouvet FE, Mason G, Mertz SA, Mueller V, Myerson C, Neciosup S, Offersen BV, Ohno S, Pagani O, Partridge AH, Penault-Llorca F, Prat A, Rugo HS, Senkus E, Sledge GW, Swain SM, Thomssen C, Vorobiof DA, Vuylsteke P, Wiseman T, Xu B, Costa A, Norton L, Winer EP. Cardoso F, et al. Breast. 2024 Aug;76:103756. doi: 10.1016/j.breast.2024.103756. Epub 2024 May 28. Breast. 2024. PMID: 38896983 Free PMC article.
Impact of coadministration of proton-pump inhibitors and palbociclib in hormone receptor-positive/HER2-negative advanced breast cancer.
Di Cosimo S, Pérez-García JM, Bellet M, Dalenc F, Gil Gil MJ, Ruiz-Borrego M, Gavilá J, Aguirre E, Schmid P, Marmé F, Gligorov J, Schneeweiss A, Albanell J, Zamora P, Wheatley D, Martínez de Dueñas E, Amillano K, Shimizu E, Sampayo-Cordero M, Cortés J, Llombart-Cussac A. Di Cosimo S, et al. Breast. 2024 Aug;76:103761. doi: 10.1016/j.breast.2024.103761. Epub 2024 Jun 11. Breast. 2024. PMID: 38880077 Free PMC article. Clinical Trial.
3,723 results